Bristol Myers Squibb (BMS) is a multinational pharmaceutical company headquartered in New York City, United States. It was founded in 1887 by William McLaren Bristol and John Ripley Myers. Over the years, BMS has grown to become one of the largest pharmaceutical companies in the world.

BMS's headquarters is located in a state-of-the-art facility in New York City. It serves as the center for the company's global operations and houses various departments, including research and development, manufacturing, marketing, and sales. The company offers a wide range of pharmaceutical products and services across multiple therapeutic areas.

Its main focus is on discovering, developing, and manufacturing innovative medicines to address unmet medical needs. BMS's key therapeutic areas include oncology, cardiology, immunology, virology, and neuroscience. BMS operates on a global scale, with a presence in more than 60 countries.

The company has several subsidiaries, including Celgene, a leading biopharmaceutical company acquired by BMS in 2019. Additionally, BMS has formed numerous strategic partnerships and collaborations with other pharmaceutical companies, academic institutions, and research organizations to advance its drug development pipeline. In terms of market position, BMS is a major player in the global pharmaceutical industry.

It has consistently ranked among the top pharmaceutical companies in terms of global sales. BMS faces competition from other large pharmaceutical companies such as Pfizer, Roche, and Novartis. However, BMS has established itself as a leader in oncology, thanks to its strong portfolio of cancer drugs.

BMS has achieved numerous milestones throughout its history. Recently, the company received approval for several groundbreaking therapies, including immunotherapy treatments for various types of cancer. These achievements have significantly contributed to the company's growth and success.

As of the latest updates, Bristol Myers Squibb continues to strive for innovation and breakthroughs in the pharmaceutical industry. The company remains committed to its mission of discovering, developing, and delivering innovative medicines that help patients combat serious diseases. BMS's ongoing success is a testament to its dedication to improving the health and well-being of people worldwide